| fat soluble vitamin biosynthetic process | GO:0042362 | 4 | 0.244 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.234 | |
| cofactor transport | GO:0051181 | 4 | 0.202 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.191 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.180 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.165 | |
| cation transport | GO:0006812 | 399 | 0.152 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.150 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.135 | |
| amine metabolic process | GO:0009308 | 45 | 0.132 | |
| brown fat cell differentiation | GO:0050873 | 36 | 0.124 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.124 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.113 | |
| anion transport | GO:0006820 | 177 | 0.110 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.094 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.093 | |
| cofactor metabolic process | GO:0051186 | 80 | 0.092 | |
| oxidation reduction process | GO:0055114 | 342 | 0.091 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.086 | |
| fat cell differentiation | GO:0045444 | 160 | 0.082 | |
| hormone secretion | GO:0046879 | 128 | 0.075 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.072 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.067 | |
| response to inorganic substance | GO:0010035 | 96 | 0.067 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.065 | |
| paraxial mesodermal cell fate commitment | GO:0048343 | 2 | 0.064 | |
| cellular homeostasis | GO:0019725 | 240 | 0.063 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.063 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.063 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.062 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.061 | |
| cellular response to metal ion | GO:0071248 | 31 | 0.058 | |
| protein maturation | GO:0051604 | 176 | 0.058 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.055 | |
| activation of immune response | GO:0002253 | 138 | 0.054 | |
| response to metal ion | GO:0010038 | 47 | 0.054 | |
| organic anion transport | GO:0015711 | 137 | 0.053 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.053 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.053 | |
| cerebellar cortex formation | GO:0021697 | 22 | 0.053 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.052 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.052 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.051 | |
| mitochondrion organization | GO:0007005 | 134 | 0.050 | |
| protein processing | GO:0016485 | 163 | 0.050 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.050 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.050 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.050 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.049 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.049 | |
| immune effector process | GO:0002252 | 321 | 0.048 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.047 | |
| regulation of secretion | GO:0051046 | 274 | 0.047 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.047 | |
| aortic valve morphogenesis | GO:0003180 | 4 | 0.047 | |
| cellular alcohol metabolic process | GO:0044107 | 3 | 0.047 | |
| cell recognition | GO:0008037 | 83 | 0.047 | |
| insulin secretion | GO:0030073 | 89 | 0.046 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.046 | |
| hexose biosynthetic process | GO:0019319 | 39 | 0.046 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.045 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.045 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.045 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.045 | |
| response to insulin | GO:0032868 | 100 | 0.044 | |
| cytokine production | GO:0001816 | 319 | 0.043 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.043 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.043 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.043 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.043 | |
| spermatogenesis | GO:0007283 | 284 | 0.042 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.042 | |
| dna metabolic process | GO:0006259 | 303 | 0.041 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.041 | |
| cerebellar cortex development | GO:0021695 | 48 | 0.040 | |
| response to peptide hormone | GO:0043434 | 127 | 0.040 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.039 | |
| chromatin modification | GO:0016568 | 187 | 0.039 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.039 | |
| spermatid development | GO:0007286 | 108 | 0.038 | |
| cell differentiation in hindbrain | GO:0021533 | 24 | 0.038 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.038 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.037 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.037 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.037 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.037 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.036 | |
| cerebellum morphogenesis | GO:0021587 | 42 | 0.036 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.036 | |
| spermatid differentiation | GO:0048515 | 115 | 0.036 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.036 | |
| drug metabolic process | GO:0017144 | 4 | 0.036 | |
| tissue homeostasis | GO:0001894 | 115 | 0.036 | |
| intestinal epithelial cell maturation | GO:0060574 | 2 | 0.035 | |
| response to growth factor | GO:0070848 | 198 | 0.035 | |
| carbon catabolite activation of transcription from rna polymerase ii promoter | GO:0000436 | 4 | 0.034 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.034 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.034 | |
| multicellular organism growth | GO:0035264 | 161 | 0.034 | |
| vitamin d biosynthetic process | GO:0042368 | 3 | 0.033 | |
| peptide secretion | GO:0002790 | 114 | 0.033 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.033 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.033 | |
| urogenital system development | GO:0001655 | 261 | 0.033 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.033 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.033 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.032 | |
| peptide transport | GO:0015833 | 133 | 0.032 | |
| negative regulation of dna binding | GO:0043392 | 20 | 0.032 | |
| regulation of system process | GO:0044057 | 200 | 0.031 | |
| inflammatory response | GO:0006954 | 244 | 0.031 | |
| icosanoid metabolic process | GO:0006690 | 33 | 0.031 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.031 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.031 | |
| extracellular structure organization | GO:0043062 | 148 | 0.031 | |
| rhythmic process | GO:0048511 | 174 | 0.031 | |
| kidney development | GO:0001822 | 213 | 0.030 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.030 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.030 | |
| sensory perception | GO:0007600 | 245 | 0.030 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.030 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.029 | |
| neuron death | GO:0070997 | 154 | 0.029 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.029 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.029 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.029 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.029 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.029 | |
| alpha amino acid metabolic process | GO:1901605 | 59 | 0.028 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.028 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.028 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.028 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.028 | |
| coenzyme metabolic process | GO:0006732 | 52 | 0.027 | |
| sperm egg recognition | GO:0035036 | 37 | 0.027 | |
| response to radiation | GO:0009314 | 165 | 0.027 | |
| vitamin metabolic process | GO:0006766 | 23 | 0.027 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.027 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.026 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.026 | |
| forebrain development | GO:0030900 | 302 | 0.026 | |
| amide transport | GO:0042886 | 138 | 0.026 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.026 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.026 | |
| binding of sperm to zona pellucida | GO:0007339 | 34 | 0.025 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.025 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.025 | |
| blood circulation | GO:0008015 | 195 | 0.025 | |
| renal system development | GO:0072001 | 225 | 0.025 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.025 | |
| regulation of cytokine secretion | GO:0050707 | 61 | 0.025 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.025 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.025 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.025 | |
| secondary alcohol metabolic process | GO:1902652 | 3 | 0.025 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.024 | |
| regulation of lymphocyte apoptotic process | GO:0070228 | 41 | 0.024 | |
| gland development | GO:0048732 | 330 | 0.024 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.024 | |
| cellular alcohol biosynthetic process | GO:0044108 | 3 | 0.024 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.024 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.024 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.024 | |
| collagen fibril organization | GO:0030199 | 32 | 0.024 | |
| paraxial mesodermal cell differentiation | GO:0048342 | 2 | 0.024 | |
| protein methylation | GO:0006479 | 81 | 0.024 | |
| regulation of binding | GO:0051098 | 111 | 0.024 | |
| organelle fission | GO:0048285 | 170 | 0.024 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.023 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.023 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.023 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.023 | |
| vitamin d3 metabolic process | GO:0070640 | 3 | 0.023 | |
| transmembrane transport | GO:0055085 | 412 | 0.023 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.023 | |
| negative regulation of secretion by cell | GO:1903531 | 54 | 0.023 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.023 | |
| organic acid transport | GO:0015849 | 101 | 0.023 | |
| trabecular meshwork development | GO:0002930 | 2 | 0.022 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.022 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.022 | |
| kidney epithelium development | GO:0072073 | 121 | 0.022 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.022 | |
| regionalization | GO:0003002 | 337 | 0.022 | |
| regulation of ion transport | GO:0043269 | 215 | 0.022 | |
| cholesterol efflux | GO:0033344 | 24 | 0.022 | |
| porphyrin containing compound metabolic process | GO:0006778 | 22 | 0.022 | |
| ectoderm formation | GO:0001705 | 3 | 0.022 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.022 | |
| interleukin 8 production | GO:0032637 | 4 | 0.022 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.022 | |
| epithelial cell development | GO:0002064 | 159 | 0.022 | |
| telencephalon development | GO:0021537 | 186 | 0.021 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.021 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.021 | |
| regulation of cell activation | GO:0050865 | 289 | 0.021 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.021 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.021 | |
| defecation | GO:0030421 | 1 | 0.021 | |
| cognition | GO:0050890 | 149 | 0.021 | |
| cell maturation | GO:0048469 | 127 | 0.021 | |
| epithelial cell maturation involved in prostate gland development | GO:0060743 | 4 | 0.021 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.021 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.021 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.021 | |
| carbon catabolite activation of transcription | GO:0045991 | 4 | 0.021 | |
| chromatin organization | GO:0006325 | 206 | 0.021 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.020 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.020 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.020 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 91 | 0.020 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.020 | |
| catecholamine metabolic process | GO:0006584 | 30 | 0.020 | |
| pallium development | GO:0021543 | 120 | 0.020 | |
| lipid catabolic process | GO:0016042 | 69 | 0.020 | |
| metencephalon development | GO:0022037 | 89 | 0.020 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.020 | |
| carbon catabolite regulation of transcription from rna polymerase ii promoter | GO:0000429 | 4 | 0.020 | |
| transcription from rna polymerase iii promoter | GO:0006383 | 3 | 0.020 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.020 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.020 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.020 | |
| regulation of protein transport | GO:0051223 | 163 | 0.019 | |
| regulation of lipid transport | GO:0032368 | 36 | 0.019 | |
| cellular response to cadmium ion | GO:0071276 | 3 | 0.019 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.019 | |
| monocarboxylic acid biosynthetic process | GO:0072330 | 61 | 0.019 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 40 | 0.019 | |
| protein ubiquitination | GO:0016567 | 171 | 0.019 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.019 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.019 | |
| calcitriol biosynthetic process from calciol | GO:0036378 | 3 | 0.019 | |
| steroid metabolic process | GO:0008202 | 119 | 0.019 | |
| carboxylic acid catabolic process | GO:0046395 | 51 | 0.019 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.019 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.019 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.019 | |
| cellular amide metabolic process | GO:0043603 | 58 | 0.019 | |
| regulation of stem cell proliferation | GO:0072091 | 78 | 0.019 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.019 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.019 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.019 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.019 | |
| one carbon metabolic process | GO:0006730 | 1 | 0.019 | |
| b cell differentiation | GO:0030183 | 78 | 0.019 | |
| protein catabolic process | GO:0030163 | 221 | 0.019 | |
| protein secretion | GO:0009306 | 111 | 0.018 | |
| amino acid transmembrane transport | GO:0003333 | 37 | 0.018 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.018 | |
| steroid biosynthetic process | GO:0006694 | 47 | 0.018 | |
| g protein coupled acetylcholine receptor signaling pathway | GO:0007213 | 4 | 0.018 | |
| wnt signaling pathway involved in forebrain neuroblast division | GO:0021874 | 2 | 0.018 | |
| methylation | GO:0032259 | 134 | 0.018 | |
| b cell activation | GO:0042113 | 161 | 0.018 | |
| positive regulation of transcription from rna polymerase ii promoter by glucose | GO:0000432 | 3 | 0.018 | |
| wnt signaling pathway involved in kidney development | GO:0061289 | 2 | 0.018 | |
| respiratory system development | GO:0060541 | 190 | 0.018 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.018 | |
| fertilization | GO:0009566 | 127 | 0.018 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.018 | |
| sensory system development | GO:0048880 | 3 | 0.018 | |
| locomotory behavior | GO:0007626 | 195 | 0.018 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.018 | |
| regulation of retina development in camera type eye | GO:1902866 | 3 | 0.018 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.018 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.018 | |
| unsaturated fatty acid metabolic process | GO:0033559 | 31 | 0.018 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.017 | |
| establishment of planar polarity involved in nephron morphogenesis | GO:0072046 | 1 | 0.017 | |
| regulation of ureteric bud formation | GO:0072106 | 3 | 0.017 | |
| negative regulation of binding | GO:0051100 | 39 | 0.017 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.017 | |
| histamine transport | GO:0051608 | 2 | 0.017 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.017 | |
| angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure | GO:0001998 | 3 | 0.017 | |
| maintenance of apical basal cell polarity | GO:0035090 | 3 | 0.017 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.017 | |
| t cell differentiation in thymus | GO:0033077 | 77 | 0.017 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.017 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.017 | |
| glucose homeostasis | GO:0042593 | 128 | 0.017 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.017 | |
| positive regulation of transcription from rna polymerase iii promoter | GO:0045945 | 1 | 0.017 | |
| insulin secretion involved in cellular response to glucose stimulus | GO:0035773 | 36 | 0.017 | |
| regulation of leukocyte mediated immunity | GO:0002703 | 104 | 0.017 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.016 | |
| mitochondrion distribution | GO:0048311 | 4 | 0.016 | |
| macromolecule methylation | GO:0043414 | 120 | 0.016 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.016 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.016 | |
| regulation of interleukin 6 production | GO:0032675 | 55 | 0.016 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.016 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.016 | |
| prostate gland development | GO:0030850 | 48 | 0.016 | |
| retina morphogenesis in camera type eye | GO:0060042 | 45 | 0.016 | |
| cell cell signaling involved in metanephros development | GO:0072204 | 2 | 0.016 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.016 | |
| neuron projection guidance | GO:0097485 | 141 | 0.016 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.016 | |
| positive regulation of fat cell differentiation | GO:0045600 | 32 | 0.016 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.016 | |
| regulation of transcription regulatory region dna binding | GO:2000677 | 9 | 0.016 | |
| male gamete generation | GO:0048232 | 285 | 0.016 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.016 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.016 | |
| cerebral cortex development | GO:0021987 | 86 | 0.016 | |
| positive regulation of tissue remodeling | GO:0034105 | 19 | 0.016 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.016 | |
| germ cell development | GO:0007281 | 185 | 0.016 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 79 | 0.015 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.015 | |
| trachea cartilage morphogenesis | GO:0060535 | 4 | 0.015 | |
| camera type eye development | GO:0043010 | 266 | 0.015 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.015 | |
| regulation of transcription by glucose | GO:0046015 | 3 | 0.015 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.015 | |
| histone modification | GO:0016570 | 159 | 0.015 | |
| rna processing | GO:0006396 | 105 | 0.015 | |
| cell cell recognition | GO:0009988 | 44 | 0.015 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.015 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.015 | |
| alcohol biosynthetic process | GO:0046165 | 43 | 0.015 | |
| megakaryocyte differentiation | GO:0030219 | 26 | 0.015 | |
| axonogenesis | GO:0007409 | 274 | 0.015 | |
| positive regulation of tumor necrosis factor production | GO:0032760 | 30 | 0.015 | |
| formation of primary germ layer | GO:0001704 | 77 | 0.015 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.015 | |
| purine ribonucleotide biosynthetic process | GO:0009152 | 59 | 0.015 | |
| cellular response to gonadotropin stimulus | GO:0071371 | 4 | 0.015 | |
| dna repair | GO:0006281 | 107 | 0.015 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.015 | |
| axis elongation involved in somitogenesis | GO:0090245 | 4 | 0.015 | |
| t cell activation | GO:0042110 | 289 | 0.015 | |
| negative regulation of secretion | GO:0051048 | 61 | 0.015 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.015 | |
| positive regulation of apoptotic process involved in morphogenesis | GO:1902339 | 4 | 0.014 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.014 | |
| metanephric capsule morphogenesis | GO:0072265 | 1 | 0.014 | |
| nuclear division | GO:0000280 | 158 | 0.014 | |
| metanephric glomerular epithelial cell development | GO:0072313 | 2 | 0.014 | |
| naphthalene containing compound metabolic process | GO:0090420 | 1 | 0.014 | |
| tissue remodeling | GO:0048771 | 102 | 0.014 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.014 | |
| t cell apoptotic process | GO:0070231 | 39 | 0.014 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.014 | |
| endocardial cushion to mesenchymal transition involved in heart valve formation | GO:0003199 | 4 | 0.014 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.014 | |
| positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process | GO:2000763 | 1 | 0.014 | |
| response to acid chemical | GO:0001101 | 111 | 0.014 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.014 | |
| neural fold elevation formation | GO:0021502 | 1 | 0.014 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.014 | |
| mitral valve morphogenesis | GO:0003183 | 4 | 0.014 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.014 | |
| cellular response to glucose stimulus | GO:0071333 | 45 | 0.014 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.014 | |
| maintenance of epithelial cell apical basal polarity | GO:0045199 | 2 | 0.014 | |
| cytokine secretion | GO:0050663 | 72 | 0.014 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.014 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.014 | |
| innate immune response | GO:0045087 | 157 | 0.014 | |
| regulation of tissue remodeling | GO:0034103 | 38 | 0.014 | |
| cyclic nucleotide biosynthetic process | GO:0009190 | 44 | 0.014 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.014 | |
| circadian regulation of gene expression | GO:0032922 | 48 | 0.014 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.013 | |
| response to drug | GO:0042493 | 75 | 0.013 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.013 | |
| nephrogenic mesenchyme development | GO:0072076 | 3 | 0.013 | |
| cerebellum development | GO:0021549 | 77 | 0.013 | |
| respiratory tube development | GO:0030323 | 167 | 0.013 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.013 | |
| response to oxidative stress | GO:0006979 | 123 | 0.013 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.013 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.013 | |
| regulation of dna binding | GO:0051101 | 39 | 0.013 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.013 | |
| nephric duct formation | GO:0072179 | 4 | 0.013 | |
| small molecule catabolic process | GO:0044282 | 71 | 0.013 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.013 | |
| regulation of peptide secretion | GO:0002791 | 77 | 0.013 | |
| regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation | GO:2000702 | 1 | 0.013 | |
| metanephric loop of henle development | GO:0072236 | 4 | 0.013 | |
| regulation of bmp signaling pathway | GO:0030510 | 60 | 0.013 | |
| cellular glucose homeostasis | GO:0001678 | 52 | 0.013 | |
| lateral line system development | GO:0048925 | 1 | 0.013 | |
| adult behavior | GO:0030534 | 135 | 0.013 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.013 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.013 | |
| mitral valve development | GO:0003174 | 4 | 0.013 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.013 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.013 | |
| monosaccharide biosynthetic process | GO:0046364 | 44 | 0.013 | |
| embryonic retina morphogenesis in camera type eye | GO:0060059 | 7 | 0.013 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.013 | |
| regulation of cellular protein catabolic process | GO:1903362 | 61 | 0.013 | |
| cervix development | GO:0060067 | 2 | 0.013 | |
| neural crest cell differentiation | GO:0014033 | 54 | 0.013 | |
| female sex differentiation | GO:0046660 | 84 | 0.013 | |
| regulation of protein processing | GO:0070613 | 96 | 0.013 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.013 | |
| folic acid containing compound metabolic process | GO:0006760 | 3 | 0.013 | |
| response to peptide | GO:1901652 | 136 | 0.013 | |
| cation homeostasis | GO:0055080 | 212 | 0.013 | |
| regulation of renal sodium excretion | GO:0035813 | 3 | 0.013 | |
| cell cell signaling involved in kidney development | GO:0060995 | 2 | 0.013 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.013 | |
| activation of adenylate cyclase activity | GO:0007190 | 4 | 0.013 | |
| granulosa cell differentiation | GO:0060014 | 1 | 0.013 | |
| response to oxygen levels | GO:0070482 | 62 | 0.013 | |
| jak stat cascade | GO:0007259 | 42 | 0.013 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.013 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.013 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.013 | |
| lipid transport | GO:0006869 | 98 | 0.013 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 82 | 0.013 | |
| cerebellar cortex morphogenesis | GO:0021696 | 32 | 0.013 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.013 | |
| positive regulation of cyclic nucleotide metabolic process | GO:0030801 | 24 | 0.013 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.013 | |
| positive regulation of lipid transport | GO:0032370 | 22 | 0.012 | |
| circulatory system process | GO:0003013 | 197 | 0.012 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.012 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.012 | |
| regulation of stress activated mapk cascade | GO:0032872 | 69 | 0.012 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.012 | |
| renal capsule morphogenesis | GO:0072128 | 1 | 0.012 | |
| visceral serous pericardium development | GO:0061032 | 2 | 0.012 | |
| transition metal ion homeostasis | GO:0055076 | 54 | 0.012 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.012 | |
| cellular response to carbohydrate stimulus | GO:0071322 | 50 | 0.012 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.012 | |
| positive regulation of purine nucleotide biosynthetic process | GO:1900373 | 26 | 0.012 | |
| peripheral nervous system neuron axonogenesis | GO:0048936 | 3 | 0.012 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.012 | |
| glomerular epithelial cell differentiation | GO:0072311 | 10 | 0.012 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.012 | |
| positive regulation of glycolytic process | GO:0045821 | 4 | 0.012 | |
| positive regulation of transcription by glucose | GO:0046016 | 3 | 0.012 | |
| body fluid secretion | GO:0007589 | 53 | 0.012 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.012 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.012 | |
| columnar cuboidal epithelial cell maturation | GO:0002069 | 4 | 0.012 | |
| regulation of steroid metabolic process | GO:0019218 | 39 | 0.012 | |
| embryonic viscerocranium morphogenesis | GO:0048703 | 8 | 0.012 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.012 | |
| mesonephric duct morphogenesis | GO:0072180 | 4 | 0.012 | |
| regulation of fatty acid metabolic process | GO:0019217 | 28 | 0.012 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.012 | |
| monoamine transport | GO:0015844 | 33 | 0.012 | |
| cyclic purine nucleotide metabolic process | GO:0052652 | 43 | 0.012 | |
| fat soluble vitamin metabolic process | GO:0006775 | 11 | 0.012 | |
| lipid oxidation | GO:0034440 | 29 | 0.012 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.012 | |
| nephron epithelium development | GO:0072009 | 92 | 0.012 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.012 | |
| secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | GO:0060528 | 4 | 0.012 | |
| olfactory learning | GO:0008355 | 2 | 0.012 | |
| activation of mapk activity involved in innate immune response | GO:0035419 | 2 | 0.012 | |
| regulation of jak stat cascade | GO:0046425 | 34 | 0.012 | |
| cytokine metabolic process | GO:0042107 | 71 | 0.012 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.012 | |
| protein activation cascade | GO:0072376 | 19 | 0.012 | |
| fatty acid derivative metabolic process | GO:1901568 | 33 | 0.012 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.012 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.012 | |
| regulation of camp biosynthetic process | GO:0030817 | 25 | 0.012 | |
| female gonad development | GO:0008585 | 71 | 0.011 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.011 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.011 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.011 | |
| cellular response to peptide | GO:1901653 | 92 | 0.011 | |
| renal sodium excretion | GO:0035812 | 3 | 0.011 | |
| regulation of peptide hormone secretion | GO:0090276 | 75 | 0.011 | |
| glomerular mesangial cell development | GO:0072144 | 3 | 0.011 | |
| regulation of cell migration | GO:0030334 | 219 | 0.011 | |
| mrna metabolic process | GO:0016071 | 84 | 0.011 | |
| negative regulation of protein transport | GO:0051224 | 46 | 0.011 | |
| cellular response to lipid | GO:0071396 | 145 | 0.011 | |
| tumor necrosis factor superfamily cytokine production | GO:0071706 | 51 | 0.011 | |
| nuclear transport | GO:0051169 | 139 | 0.011 | |
| apoptotic process involved in mammary gland involution | GO:0060057 | 4 | 0.011 | |
